- Home
- GROW vs ANTX Comparison
GROW vs ANTX Comparison
Compare GROW & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- ANTX
- Stock Information
- Founded
- GROW 1968
- ANTX 2017
- Country
- GROW United States
- ANTX United States
- Employees
- GROW N/A
- ANTX N/A
- Industry
- GROW Investment Managers
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- ANTX Health Care
- Exchange
- GROW Nasdaq
- ANTX Nasdaq
- Market Cap
- GROW 31.8M
- ANTX 33.2M
- IPO Year
- GROW N/A
- ANTX 2022
- Fundamental
- Price
- GROW $2.43
- ANTX $1.08
- Analyst Decision
- GROW
- ANTX Buy
- Analyst Count
- GROW 0
- ANTX 2
- Target Price
- GROW N/A
- ANTX $2.00
- AVG Volume (30 Days)
- GROW 38.8K
- ANTX 71.3K
- Earning Date
- GROW 09-09-2025
- ANTX 08-12-2025
- Dividend Yield
- GROW 3.66%
- ANTX N/A
- EPS Growth
- GROW N/A
- ANTX N/A
- EPS
- GROW 0.01
- ANTX N/A
- Revenue
- GROW $8,932,000.00
- ANTX N/A
- Revenue This Year
- GROW N/A
- ANTX N/A
- Revenue Next Year
- GROW N/A
- ANTX N/A
- P/E Ratio
- GROW $233.35
- ANTX N/A
- Revenue Growth
- GROW N/A
- ANTX N/A
- 52 Week Low
- GROW $2.02
- ANTX $0.87
- 52 Week High
- GROW $2.69
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- GROW 57.74
- ANTX 45.36
- Support Level
- GROW $2.43
- ANTX $1.05
- Resistance Level
- GROW $2.58
- ANTX $1.16
- Average True Range (ATR)
- GROW 0.06
- ANTX 0.03
- MACD
- GROW -0.00
- ANTX 0.00
- Stochastic Oscillator
- GROW 65.22
- ANTX 18.87
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.